HAART regimens: reduced mortality vs non-HAART therapy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1622, 2008-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Saquinavir-soft gel: establishing saquinavir in HAART regimens

By Moyle G.J.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 8, 1998-08 ,pp. : 1313-1322

Informa Healthcare

Access to resources Recommend Favorite

HAART use affects mortality in AIDS in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 420, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) Regimens: A Cross-Sectional, Observational Study

By Guaraldi Giovanni  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 759-767

Adis International

Access to resources Recommend Favorite

Protease inhibitor (PI)-containing HAART is associated with a reduced bone mineral density

By  

Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Protease inhibitor (PI)-containing HAART is associated with a reduced bone mineral density

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite